prikaz prve stranice dokumenta The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis
  Download
PDF 632.52 KB
Scientific paper - Review paper
The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis
Biomolecules, 9 (2019), 9; https://doi.org/10.3390/biom9090416
Mahdavi Gorabi, Armita; Kiaie, Nasim; Reiner, Željko; Carbone, Federico; Montecucco, Fabrizio; Sahebkar, Amirhossein

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Mahdavi Gorabi, A., Kiaie, N., Reiner, Ž., Carbone, F., Montecucco, F. & Sahebkar, A. (2019). The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis. Biomolecules, 9. (9). doi: 10.3390/biom9090416

Mahdavi Gorabi, Armita, et al. "The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis." Biomolecules, vol. 9, no. 9, 2019. https://doi.org/10.3390/biom9090416

Mahdavi Gorabi, Armita, Nasim Kiaie, Željko Reiner, Federico Carbone, Fabrizio Montecucco and Amirhossein Sahebkar. "The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis." Biomolecules 9, no. 9 (2019). https://doi.org/10.3390/biom9090416

Mahdavi Gorabi, A., et al. (2019) 'The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis', Biomolecules, 9(9). doi: 10.3390/biom9090416

Mahdavi Gorabi A, Kiaie N, Reiner Ž, Carbone F, Montecucco F, Sahebkar A. The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis. Biomolecules [Internet]. 2019 August 26 [cited 2024 December 25];9(9). doi: 10.3390/biom9090416

A. Mahdavi Gorabi, N. Kiaie, Ž. Reiner, F. Carbone, F. Montecucco and A. Sahebkar, "The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis", Biomolecules, vol. 9, no. 9, August 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:464916. [Accessed: 25 December 2024]

Metadata
Title (english)The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis
AuthorArmita Mahdavi Gorabi
AuthorNasim Kiaie
AuthorŽeljko Reiner
AuthorFederico Carbone
AuthorFabrizio Montecucco
AuthorAmirhossein Sahebkar
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Chronic inflammation is one of the main determinants of atherogenesis. The traditional medications for treatment of atherosclerosis are not very efficient in targeting atherosclerotic inflammation. Most of these drugs are non-selective, anti-inflammatory and immunosuppressive agents that have adverse effects and very limited anti-atherosclerotic effects, which limits their systemic administration. New approaches using nanoparticles have been investigated to specifically deliver therapeutic agents directly on atherosclerotic lesions. The use of drug delivery systems, such as polymeric nanoparticles, liposomes, and carbon nanotubes are attractive strategies, but some limitations exist. For instance, nanoparticles may alter the drug kinetics, based on the pathophysiological mechanisms of the diseases. In this review, we will update pathophysiological evidence for the use of nanoparticles to reduce inflammation and potentially prevent atherogenesis in different experimental models.
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleBiomolecules
Numberingvol. 9, no. 9
p-ISSN2218-273X
DOIhttps://doi.org/10.3390/biom9090416
URN:NBNurn:nbn:hr:105:464916
Publication2019-08-26
Document URLhttp://doi.org/10.3390/biom9090416
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 10:37:32